Abstract
Health technology assessments of interventions impacting survival often require extrapolating current data to gain a better understanding of the interventions’ long-term benefits. Both a comprehensive examination of the trial data up to the maximum follow-up period and the fitting of parametric models are required for extrapolation. It is standard practice to visually compare the parametric curves to the Kaplan-Meier survival estimate (or comparison of hazard estimates) and to assess the parametric models using likelihood-based information criteria. In place of these two steps, this work demonstrates how to minimize the squared distance of parametric estimators to the Kaplan-Meier estimate. This is in line with the selection of the model using Mean Squared Error, with the modification that the unknown true survival is replaced by the Kaplan-Meier estimate. We would assure the internal validity of the extrapolated model and its appropriate representation of the data by adhering to this procedure. We use both simulation and real-world data with a scenario where no model that properly fits the data could be found to illustrate how this process can aid in model selection.
Reference31 articles.
1. A review of survival analysis methods used in nice technology appraisals of cancer treatments: consistency, limitations, and areas for improvement.;Bell Gorrod;Medical Decision Making,2019
2. Comparing survival extrapolation within all-cause and relative survival frameworks by standard parametric models and flexible parametric spline models using the swedish cancer registry.;Chen;Medical Decision Making,2024
3. The focused information criterion.;Claeskens;Journal of the American Statistical Association,2003
4. Claeskens, G., Hjort, N. L., et al. (2008). Model selection and model averaging, volume 330. Cambridge University Press Cambridge.
5. Cramer, H. (1946). Mathematical methods of statistics. Princeton mathematical series. Princeton Univ. Press, Princeton, NJ.